Valuation: Procter & Gamble Health Limited

Market Cap 89.04B 926M 823M 768M 700M 1.32B 1.33B 9.29B 3.6B 45.52B 3.48B 3.4B 146B P/E 2027 *
24.2x
P/E 2028 * 21.8x
Enterprise Value 89.04B 926M 823M 768M 700M 1.32B 1.33B 9.29B 3.6B 45.52B 3.48B 3.4B 146B EV / Sales 2027 *
5.75x
EV / Sales 2028 * 5.11x
Free-Float
47.81%
Yield 2027 *
2.03%
Yield 2028 * 2.2%
1 day-3.55%
1 week-0.93%
Current month-3.55%
1 month-6.91%
3 months-15.68%
6 months+12.44%
Current year-5.91%
1 week 5,305.5
Extreme 5305.5
5,875
1 month 5,305.5
Extreme 5305.5
5,875
Current year 4,699.7
Extreme 4699.7
6,955
1 year 4,699.7
Extreme 4699.7
6,955
3 years 4,640.3
Extreme 4640.3
6,955
5 years 3,883
Extreme 3883
6,955
10 years 697
Extreme 697
7,499.95
Manager TitleAgeSince
Chief Executive Officer 57 01/04/2018
Director of Finance/CFO - 01/10/2025
Chief Tech/Sci/R&D Officer - 01/09/2025
Director TitleAgeSince
Director/Board Member 57 01/04/2018
Director/Board Member 51 01/06/2019
Chairman 70 01/04/2025
Change 5-day change 1-year change 3-year change Capi.($)
-3.55%-0.93%-14.40%+5.15% 926M
-0.61%-3.43%+36.07%+117.61% 1,019B
-1.02%-5.60%+35.72%+64.82% 617B
+1.11%-0.58%+12.36%+78.27% 464B
+0.34%-3.01%+61.79%+41.79% 356B
-0.95%-4.05%+20.54%+40.33% 333B
-1.46%-2.89%+10.57%+26.54% 267B
-1.35%-5.43%-6.17%+8.82% 244B
-1.04%-2.79%+35.30%+54.42% 218B
-1.87%-4.10%+28.44%+97.54% 179B
Average -1.04%-3.16%+22.02%+53.53% 369.81B
Weighted average by Cap. -0.60%-3.32%+29.06%+71.14%

Financials

2027 *2028 *
Net sales 15.47B 161M 143M 133M 122M 229M 232M 1.62B 626M 7.91B 604M 591M 25.39B 17.43B 181M 161M 150M 137M 259M 261M 1.82B 705M 8.91B 681M 666M 28.6B
Net income 3.67B 38.19M 33.93M 31.67M 28.87M 54.44M 54.95M 383M 149M 1.88B 143M 140M 6.02B 4.09B 42.51M 37.77M 35.26M 32.13M 60.61M 61.17M 427M 165M 2.09B 160M 156M 6.71B
Net Debt - -
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,276
Date Price Change Volume
01/10/26 ₹5,363.95 -3.55% 276
30/09/26 ₹5,561.10 -2.72% 522
29/09/26 ₹5,716.50 +5.75% 4,128
28/09/26 ₹5,405.60 -0.16% 261
25/09/26 ₹5,414.15 -0.17% 306
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGHL Stock